BioCentury
ARTICLE | Clinical News

Vonapanitase: Ph III PATENCY-1 data

December 16, 2016 8:24 PM UTC

Top-line data from the double-blind, U.S. Phase III PATENCY-1 trial in 313 CKD patients receiving or expecting hemodialysis who underwent surgical creation of a radiocephalic AVF showed that a single ...

BCIQ Company Profiles

Proteon Therapeutics Inc.

BCIQ Target Profiles

Elastin (ELN)